Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Genentech Inc. published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-12 of 62
» View latimes.com items only
    Apr 18, 2012 |Story| Los Angeles Times

  1. Roche won't extend $6.8 billion bid for San Diego's Illumina

    Swiss drugmaker Roche will not extend its hostile $6.8-billion bid for Illumina Inc. after the San Diego biotech company’s shareholders rejected Roche’s attempts to appoint new board members.
    Swiss drugmaker Roche will not extend its hostile $6.8-billion bid for Illumina Inc. after the San Diego biotech company’s shareholders rejected Roche’s attempts to appoint new board members. Roche’s current offer of $51 per Illumina...

    Tags: Companies and Corporations, Jay T. Flatley, Genes and Chromosomes, Shareholders, Cancer

    2. Apr 19, 2012 |Story| Los Angeles Times

  2. Roche set to drop bid for Illumina

    Swiss drug maker Roche Holding said it was prepared to walk away from its attempt to take over Illumina Inc. after the San Diego biotech company's shareholders rejected Roche's attempts to appoint new board members. Roche's current offer of $51 per...

    Tags: Companies and Corporations, Jay T. Flatley, Genes and Chromosomes, Shareholders, Severin Schwan

    3. Jan 30, 2012 |Story| Los Angeles Times

  3. New Avastin tests add to confusion over use in breast cancer

    In November, following an emotional public hearing some months earlier, the Food and Drug Administration withdrew approval for the cancer drug Avastin for patients with metastatic breast cancer — the late-stage, incurable form of the disease. The reason: emerging evidence that the drug does not prolong life and also that it's been linked to serious side effects.
    In November, following an emotional public hearing some months earlier, the Food and Drug Administration withdrew approval for the cancer drug Avastin for patients with metastatic breast cancer — the late-stage, incurable form of the disease. The...

    Tags: Oncology, Health Organizations, Lymphatic System, Mastectomy, Virginia Commonwealth University

    4. Feb 1, 2012 |Story| Los Angeles Times

  4. Columbus salami factory fined $700,000 for ammonia leak

    Salami with Pinot Grigio: good pair. Salami with more than 400 pounds of leaked ammonia: not quite as tasty, as Columbus Foods continues to discover.
    Salami with Pinot Grigio: good pair. Salami with more than 400 pounds of leaked ammonia: not quite as tasty, as Columbus Foods continues to discover. The company – which makes salami, deli meats and cheeses for sale at retailers such as Albertsons,...

    Tags: Companies and Corporations, Punishment, Companies and Corporations, Environmental Issues, Salami

    5. Nov 15, 2011 | Los Angeles Times

  5. Disney CEO Iger joins Apple board; Levinson named chairman

    Technology
    In the first change to Apple's boardroom since the death of Steve Jobs last month, the company announced that Walt Disney Co. President and Chief Executive Robert Iger will be the Cupertino electronics maker's newest board member....
    6. Aug 24, 2011 | Los Angeles Times

  6. What does Steve Jobs' chairman role mean for Apple?

    L.A. Times Tech Blog
    What does Steve Jobs' chairman role mean for Apple?: Steve Jobs' resignation as Apple Inc.'s CEO might seem like a step out of the spotlight at the world's largest company. But it is possible that little may change in the executive shuffle and in fact,...
    7. Aug 24, 2011 | Los Angeles Times

  7. Steve Jobs resigns as Apple's CEO, named Chairman

    L.A. Times Tech Blog
    Steve Jobs has resigned as Apple's CEO and COO Tim Cook is set to take over: Steve Jobs has resigned his post as CEO at Apple Inc. Tim Cook, Apple's chief operating officer who has been filling in for Jobs since the company co-founder took his second...
    8. Jun 28, 2011 | Los Angeles Times

  8. Avastin: There's the truth and then there's the politics behind the cancer drug [The conversation]

    Opinion L.A.
    Avastin: The FDA goes up against drug manufacturer Genentech with regards to the late-stage cancer drug....
    9. Feb 17, 2011 | Los Angeles Times

  9. Official list of attendees at Obama tech meeting: CEOs of Twitter, Netflix, Oracle, Yahoo, others

    L.A. Times Tech Blog
    Here's the official list of attendees of Thursday evening's meeting of technology industry chiefs with President Obama in San Francisco. It includes many of Silicon Valley's biggest names. John Doerr, partner, Kleiner Perkins Caufield & Byers Carol Bartz,...
    10. Feb 21, 2011 | Los Angeles Times

  10. Obama tech dinner: Company spending figures for D.C. lobbying, campaign contributions

    L.A. Times Tech Blog
    Most of the hype around President Barack Obama's dinner with a dozen of California's tech-industry leaders was around the appearance of Apple CEO Steve Jobs as he struggles with health issues. But the dinner, which took place last Thursday, wasn't about...
    11. Apr 8, 2011 | Los Angeles Times

  11. Could a government shutdown silence Congress on Facebook?

    L.A. Times Tech Blog
    A federal government shutdown could close the National Zoo, Smithsonian museums and national parks. It could also reveal which members of Congress are social media whizzes and which ones lean on staffers for their tweets and updates. If a shutdown......
    12. Dec 7, 2010 | Los Angeles Times

  12. Michael Hiltzik: California, chump

    Money & Company
    The claim that California corporate taxes are driving away business, often made by the California Chamber of Commerce, always has had the acrid odor of special pleading. California business taxes, taken all together, are actually lower than those of many....
 1  2 3 4 5 6 • Next >
Original site for Genentech Inc. topic gallery.
Advertisement